Clinical Study Results
Where can I learn more about this study?
More information about this study is available on the website listed below. If a full report of the
study results is available, it can also be found here.
• www.clinicaltrials.gov Once you are on this website, type “NCT03216278” into the search
box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D1691C00016”
into the search box, and click “Find a Study”.
Full Trial Title: A four-part bioequivalence study to compare two fixed-dose combination (FDC)
tablets of dapagliflozin/metformin XR 5/500 mg (Part 1 and 2) and 10/1000 mg (Part 3 and 4)
manufactured at two different plants (Humacao, Puerto Rico and Mount Vernon, US) in healthy
subjects under fasting and fed conditions
National Clinical Trials number: NCT03216278
AstraZeneca Protocol Number: D1691C00016
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and
find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 0.14 2019_10_02 12